Drug delivery. Drugs on target - PubMed (original) (raw)

. 2001 Jul 6;293(5527):58-9.

doi: 10.1126/science.1063273.

Affiliations

• PMID: 11441170
• DOI: 10.1126/science.1063273

Drug delivery. Drugs on target

R Langer. Science. 2001.

No abstract available

PubMed Disclaimer

Similar articles

• The Gene Pill and its therapeutic applications.
  Sheu E, Rothman S, German M, Wang X, Finer M, McMahon BM. Sheu E, et al. Curr Opin Mol Ther. 2003 Aug;5(4):420-7. Curr Opin Mol Ther. 2003. PMID: 14513686 Review.
• Soluble sustained release gene delivery system.
  Bachrach G, Friedman M, Gilinski G, Steinberg D. Bachrach G, et al. J Biomed Mater Res A. 2006 Jun 15;77(4):811-4. doi: 10.1002/jbm.a.30675. J Biomed Mater Res A. 2006. PMID: 16575909
• Cyclodextrins in drug delivery.
  Loftsson T, Jarho P, Másson M, Järvinen T. Loftsson T, et al. Expert Opin Drug Deliv. 2005 Mar;2(2):335-51. doi: 10.1517/17425247.2.1.335. Expert Opin Drug Deliv. 2005. PMID: 16296758 Review.
• Development of PMMA membranes functionalized with hydroxypropyl-beta-cyclodextrins for controlled drug delivery using a supercritical CO(2)-assisted technology.
  Temtem M, Pompeu D, Jaraquemada G, Cabrita EJ, Casimiro T, Aguiar-Ricardo A. Temtem M, et al. Int J Pharm. 2009 Jul 6;376(1-2):110-5. doi: 10.1016/j.ijpharm.2009.04.029. Epub 2009 May 3. Int J Pharm. 2009. PMID: 19409460
• The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
  Laube BL. Laube BL. Respir Care. 2005 Sep;50(9):1161-76. Respir Care. 2005. PMID: 16122400 Review.

Cited by

• Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans.
  Arora P, Sindhu A, Dilbaghi N, Chaudhury A, Rajakumar G, Rahuman AA. Arora P, et al. J Cell Mol Med. 2012 Sep;16(9):1991-2000. doi: 10.1111/j.1582-4934.2012.01534.x. J Cell Mol Med. 2012. PMID: 22260258 Free PMC article. Review.
• Engineering the pH-Sensitivity of the Graphene and Carbon Nanotube Based Nanomedicines in Smart Cancer Therapy by Grafting Trimetyl Chitosan.
  Khoshoei A, Ghasemy E, Poustchi F, Shahbazi MA, Maleki R. Khoshoei A, et al. Pharm Res. 2020 Aug 3;37(8):160. doi: 10.1007/s11095-020-02881-1. Pharm Res. 2020. PMID: 32747991 Free PMC article.
• Subcellular targeting strategies for drug design and delivery.
  Rajendran L, Knölker HJ, Simons K. Rajendran L, et al. Nat Rev Drug Discov. 2010 Jan;9(1):29-42. doi: 10.1038/nrd2897. Nat Rev Drug Discov. 2010. PMID: 20043027 Review.
• Frontiers in cancer nanomedicine: directing mass transport through biological barriers.
  Ferrari M. Ferrari M. Trends Biotechnol. 2010 Apr;28(4):181-8. doi: 10.1016/j.tibtech.2009.12.007. Epub 2010 Jan 14. Trends Biotechnol. 2010. PMID: 20079548 Free PMC article. Review.
• HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.
  Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno AF, Zhang L, Pridgen E, Wang AZ, Marein SL, Westerhof K, Molnar LK, Farokhzad OC. Alexis F, et al. ChemMedChem. 2008 Dec;3(12):1839-43. doi: 10.1002/cmdc.200800122. ChemMedChem. 2008. PMID: 19012296 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information